Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Oculus Launches Dermacyn™ in China

publication date: Sep 12, 2008

Oculus Innovative Sciences is launching its Dermacyn™ wound treatment product in China by sending samples of the product to hospitals in ten China provinces. Sinopharm, the company in charge of China distribution of the product, also featured Dermacyn at a recent trade show, the New Drugs China Expo sponsored by Health Tech Forum 2008. The product was approved by the SFDA in March of this year to treat acute and chronic wounds including ulcers, cuts, contusions and burns. More details...

Stock Symbol: (NSDQ: OCLS)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital